Company | Cap $ | P/E | P/B | P/S | ROE | ROA | ROS | L/A | P/FCF | PR | Period |
---|---|---|---|---|---|---|---|---|---|---|---|
Endo International | 0 | 2023q2 | |||||||||
WiSA Technologies | 0 | 2023q2 | |||||||||
Bellerophon Therapeutics | 1 | 2021 | |||||||||
Jaguar Health | 1 | 2022 | |||||||||
Greenlane Holdings | 2 | 2023q2 | |||||||||
Power REIT | 2 | 2021 | |||||||||
ΠΠ Π | 3 | 2021 | |||||||||
ΠΠΠ¦Π | 3 | 2022 | |||||||||
VivoPower International | 4 | 2023 | |||||||||
22nd Century Group | 4 | 2023q3 | |||||||||
CV Sciences | 4 | 2021 | |||||||||
Telo Genomics | 6 | 2022 | |||||||||
Galera Therapeutics | 6 | 2021 | |||||||||
ΠΠ³ΡΠΎΡΠΈΡΠΌΠ° ΠΡΠ΅Π½ΡΠΊΠ°Ρ | 7 | 2022 | |||||||||
China Recycling Energy | 9 | 2022 | |||||||||
Motus GI Holdings | 9 | 2022q3 | |||||||||
Π‘Π²Π΅ΡΠΎΡΠΎΡ ΠΡΡΠΏΠΏ | 9 | 2020 | |||||||||
Desert Gold Ventures | 10 | 2021 | |||||||||
Aytu BioPharma | 10 | 2022 | |||||||||
HeartCore Enterprises | 10 | 2023q3 |